Bone Marrow Treatment for ILD

Interstitial lung disease (ILD) is an umbrella term used to categorize over 100 different types of pulmonary disorders that affect the absorption of oxygen into the lungs. It includes a diverse collection of illnesses with a variety of causes, treatments and prognoses. Individuals who suffer from ILD often have difficulty breathing and moving from place to place due to a consistent feeling of shortness of breath. Disorders classified under ILD are often characterized by scarring of the lung’s delicate tissues and a dry, pestering cough.

Previously treatment options for those suffering from interstitial lung disease have been extremely limited and costly, ranging from daily medication to a lung reduction or transplant. Today, however, relatively new technology gives lung disease sufferers an alternative option: Bone Marrow Treatment for ILD. Minimally invasive bone marrow treatments for lung disease have helped several patients regain a better quality of life. The Lung Institute specializes in stem cell therapy treatments for those suffering from lung disease.

Bone Marrow Treatment for ILD

So how does bone marrow stem cell therapy work? Over the course of three days, a patient’s stem cells will be harvested from his or her bone marrow, processed and reintroduced into their body. After reintroduction, the stem cells can begin to slow down the progression of the disease and improve lung function. Everyone has stem cells in their own body that act the body’s system to promote healing. Extracting and reintroducing stem cells to certain damaged areas of the body accelerates this process.

What Can You Expect

The bone marrow procedure is a hybrid treatment that takes place over the course of three days in a clinical outpatient setting. Before treatment can begin, the patient must complete all bloodwork, paperwork and prerequisite testing, which typically includes an electrocardiogram (EKG) and a pulmonary function test. After this necessary evaluation, the patient can visit one of our state-of-the-art Lung Institute clinics to begin treatment.

For the next few days, the patient will spend a few hours in the clinic each day. On the first day of treatment, the patient will receive the venous procedure, which uses an IV to collect a blood sample. The second day consists of the bone marrow aspiration, which removes a small amount of bone marrow fluid. Each day, the clinicians will process the stem cells from the blood or bone marrow so that they can be reintroduced to the damaged area intravenously. After reintroduction, the stem cells can begin to promote healing and improve your lung function.

Patients are often surprised by the simplicity of these minimally invasive procedures, but with cutting-edge technology and a patient-centric clinical team, patients can rest assured that they are in good hands. Throughout the entire treatment process, patients have the opportunity to get any questions immediately answered by our knowledgeable medical staff. The Lung Institute clinical team remains in contact with patients after treatment and works together with the patient’s physician and pulmonologist to create a strong support system for the patient.

One patient, Gary W., describes how treatment with the Lung Institute has improved his condition. “It’s worked. It’s done a great job for me, we can tell the difference. In fact, so well that we’re leaving tomorrow morning for Vegas. Last couple times we’ve been there we haven’t left our condo but 2-3 days out of the week because I couldn’t breathe, I couldn’t walk… not so this year. I can walk, I can talk. Unlike before, I wouldn’t be able to finish a whole sentence without taking a deep breath. None of that exists anymore.”

If you or a loved one is suffering from a lung disease, contact us today at (800) 729-3065 to see if you qualify.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.